1
Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Condition(s):Ascites; Liver CirrhosisLast Updated:May 18, 2016Terminated
Satavaptan as an Intervention: 11 Clinical Trials, Page 1 of 2
Hide Studies Not Open or Pending
2
Satavaptan in the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver
Condition(s):Ascites; Liver CirrhosisLast Updated:May 24, 2016Terminated
3
A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional Hyponatremia
Condition(s):Hyponatremia; Inappropriate ADH SyndromeLast Updated:May 26, 2016Terminated
4
Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)
Condition(s):Ascites; Liver CirrhosisLast Updated:May 26, 2016Completed
5
Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites
Condition(s):Ascites; Liver CirrhosisLast Updated:January 12, 2009Completed
6
Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites
Condition(s):Ascites; Liver CirrhosisLast Updated:July 16, 2007Completed
7
Satavaptan Dose-Ranging Study in the Prevention of Ascites
Condition(s):Ascites; Liver CirrhosisLast Updated:January 12, 2009Completed
8
Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Condition(s):Syndrome of Inappropriate ADH (SIADH) Secretion; HyponatremiaLast Updated:June 17, 2008Completed
9
Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Condition(s):Inappropriate ADH Syndrome; HyponatremiaLast Updated:January 21, 2009Completed
10
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion
Condition(s):Inappropriate ADH Syndrome; HyponatremiaLast Updated:December 10, 2008Completed